Trending stocks today
Vertex Pharmaceuticals Inc. (VRTX-Q)
NASDAQ:VRTX
459.00
3.58
(0.77%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
This summary was created by AI, based on 10 opinions in the last 12 months.
Vertex Pharmaceuticals Inc. (VRTX-Q) has been experiencing a notable increase in stock value, up approximately 20% this year, largely attributed to the successful launch of its new pain medication. However, opinions among experts vary regarding the future prospects of the company. While some analysts express optimism about the potential of their non-addictive painkillers and forthcoming FDA approvals, others are concerned due to recent disappointing news about a key drug and issues like negative free cash flow heading into 2024. Despite short-term fluctuations and profit-taking actions observed after a significant increase since 2021, the overall sentiment leans towards a belief in the company’s long-term potential, especially given its strong cystic fibrosis franchise and advancements in pain management. The mixed reviews highlight both immediate challenges and long-term growth prospects for Vertex Pharmaceuticals.
$469.970
Owned
They got disappointing news on their wonder drug. Disappointing. Doesn't see upside for the company.
He likes it for developing non-addictive painkillers with potential FDA approvals ahead. They reported a great quarter a day before the election, but has since pulled back hard that baffles him. Looks like profit-taking in a stock that's jumped 113% since end-2021.
Their anti-pain drug is not addictive and it works. He's a believer.
Negative free cash flow to enter 2024, but it's turning positive. Shares are up 21% this year.
Even at this all time high don't sell. They're working on non-addictive painkillers
It's doing well, hitting new highs today. It's further along in its life cycle. Has a fine cystic fibrosis franchise. Shares are strong momentum, so he's staying in.
This drugmaker has a lock on MS and have new shots on pain management and other maladies. Lots going on. Up sharply this month.
Likes it for its CF franchise.
Likes it, but she trimmed it because a lot of the good news from its pain medicine is now in the stock.
PPH, an ETF for pharma producers, is breaking out and near a record. VTX and Eli Lilly are leaders in this space and Vertex has a great product for Cystic Fibrosis therapeutics. It is growing well and not too expensive.
Our PAST TOP PICK with VRTX has triggered its stop at $350. To remain disciplined, we recommend covering the position at this time. This will result in a net investment gain of 44%, when combined with our previous recommendations.
They're in the MS business, so will they expand beyond MS? HE's confident they will and have some hit drugs.
A high-quality biopharma with a strong cystic fibrosis drug. Are trying to get into other franchises like diabetes treatments. Will do well long-run. Trades at 23x with 11% earnings growth, so you can take some profits now. Had a good run, so take some money off the table.
Vertex Pharmaceuticals Inc.(VRTX-Q) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 5
Neutral - Hold Signals / Votes : 2
Bearish - Sell Signals / Votes : 3
Total Signals / Votes : 10
Vertex Pharmaceuticals Inc.(VRTX-Q) Frequently Asked Questions
What is Vertex Pharmaceuticals Inc. stock symbol?
Vertex Pharmaceuticals Inc. is a American stock, trading under the symbol VRTX-Q on the NASDAQ (VRTX). It is usually referred to as NASDAQ:VRTX or VRTX-Q
Is Vertex Pharmaceuticals Inc. a buy or a sell?
In the last year, 10 stock analysts published opinions about VRTX-Q. 5 analysts recommended to BUY the stock. 3 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Vertex Pharmaceuticals Inc..
Is Vertex Pharmaceuticals Inc. a good investment or a top pick?
Vertex Pharmaceuticals Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Vertex Pharmaceuticals Inc..
Why is Vertex Pharmaceuticals Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Vertex Pharmaceuticals Inc. worth watching?
10 stock analysts on Stockchase covered Vertex Pharmaceuticals Inc. In the last year. It is a trending stock that is worth watching.
What is Vertex Pharmaceuticals Inc. stock price?
On 2025-02-14, Vertex Pharmaceuticals Inc. (VRTX-Q) stock closed at a price of $459.
She trimmed it because it's up 20% this year because of the launch of their pain medicine. Tonight's earnings will be fine and their pipeline makes it a good stock long term.